Sexually transmissible infection control programs for men who have sex with men – what will they look like in 2020?
Oliver N. Refugio A D , Chelsea Roberts A , Richard West B and Jeffrey D. Klausner A CA David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
B Directorate of Sexual Health and HIV, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
C Fielding School of Public Health, University of California, Los Angeles, 540 Charles E Young Drive, Los Angeles, CA 90024, USA.
D Corresponding author. Email: orefugio@mednet.ucla.edu
Sexual Health 14(1) 126-132 https://doi.org/10.1071/SH16038
Submitted: 11 March 2016 Accepted: 2 May 2016 Published: 22 July 2016
Journal Compilation © CSIRO Publishing 2017 Open Access CC BY-NC-ND
Abstract
The resurgence of sexually transmissible infections among men who have sex with men is a concern for sexual health. Traditional strategies have relied on the promotion of condom use, regular testing, treatment, and partner management. Future sexually transmissible infection control programs must combine current prevention methods with novel approaches that target the providers, patients, and mechanisms of health care delivery.
References
[1] Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75 3–17.| From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1MznslCntg%3D%3D&md5=74001a199fce1c9cbcc260ee6474b808CAS | 10448335PubMed |
[2] Solomon MM, Mayer KH. Evolution of the syphilis epidemic among men who have sex with men. Sex Health 2015; 12 96–102.
| Evolution of the syphilis epidemic among men who have sex with men.Crossref | GoogleScholarGoogle Scholar |
[3] Nicoll A, Hamers FF. Are trends in HIV, gonorrhoea, and syphilis worsening in Western Europe? BMJ 2002; 324 1324–7.
| Are trends in HIV, gonorrhoea, and syphilis worsening in Western Europe?Crossref | GoogleScholarGoogle Scholar | 12039830PubMed |
[4] Fenton KA, Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why? Infect Dis Clin North Am 2005; 19 311–31.
| Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why?Crossref | GoogleScholarGoogle Scholar | 15963874PubMed |
[5] Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2014. Atlanta: U.S. Department of Health and Human Services; 2015.
[6] European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe 2013. Stockholm: ECDC; 2015.
[7] The Kirby Institute. HIV, viral hepatitis, and sexually transmissible infections in Australia. Annual surveillance report 2015. Sydney: The Kirby Institute, University of New South Wales; 2015.
[8] Klausner JD. AIDS and sexually transmitted disease prevention and control. In Mayer KH, Pizer HF, editors. The AIDS pandemic: impact on science and society, 4th edn. San Diego: Academic Press; 2004. pp. 110–136.
[9] Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse. A review. Sex Transm Dis 1997; 24 11–7.
| Use and effectiveness of condoms during anal intercourse. A review.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s7ntFGlsg%3D%3D&md5=ec0d73c8d12d0859ae1304e5f1d4d98dCAS | 9018778PubMed |
[10] Centers for Disease Control and Prevention. HIV infection risk, prevention, and testing behaviors among men who have sex with men – National HIV Behavioral Surveillance, 20 U.S. cities, 2014. HIV Surveillance Special Report 15. Atlanta: Centers for Disease Control and Prevention; 2016.
[11] Belcher L, Sternberg MR, Wolitski RJ, Halkitis P, Hoff C, Team the SUMS Condom use and perceived risk of HIV transmission among sexually active HIV-positive men who have sex with men AIDS Ed 2005; 17 79–89.
[12] Ostergren JE, Rosser BRS, Horvath KJ. Reasons for non-use of condoms among men who have sex with men: a comparison of receptive and insertive role in sex and online and offline meeting venue. Cult Health Sex 2011; 13 123–40.
| Reasons for non-use of condoms among men who have sex with men: a comparison of receptive and insertive role in sex and online and offline meeting venue.Crossref | GoogleScholarGoogle Scholar | 20967649PubMed |
[13] Kent CK, Chaw JK, Wonq W, Liska S, Gibson S, Hubbard G, et al Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41 67–74.
| Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.Crossref | GoogleScholarGoogle Scholar | 15937765PubMed |
[14] Barbee LA, Dhanireddy S, Tat SA, Marrazzo JM. Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care. Sex Transm Dis 2015; 42 590–4.
| Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care.Crossref | GoogleScholarGoogle Scholar | 26372931PubMed |
[15] Blair JM, Fagan JL, Frazier EL, Do A, Bradley H, Valverde EE, et al Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009. MMWR Surveill Summ 2014; 63 1–22.
[16] Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sex Transm Dis 2011; 38 922–4.
| Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 21934565PubMed |
[17] Patton ME, Kidd S, Llata E, Stenger M, Braxton J, Asbel L, et al Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men-STD Surveillance Network, United States, 2010–2012. Clin Infect Dis 2014; 58 1564–70.
| Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men-STD Surveillance Network, United States, 2010–2012.Crossref | GoogleScholarGoogle Scholar | 24647015PubMed |
[18] Bernstein KT, Bolan R, Gibson S, Golden M, Gratzer B, Guerry S. Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations–five cities, United States, 2007. MMWR Morb Mortal Wkly Rep 2009; 58 716–9.
[19] Ota KV, Tamari IE, Smieja M, Jamieson F, Jones KE, Towns L, et al Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex Transm Infect 2009; 85 182–6.
| Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1MznsFCqsA%3D%3D&md5=f9d256232e9063f459b2acdee782bc3dCAS | 19126571PubMed |
[20] Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35 637–42.
| Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXnslagu70%3D&md5=a5bc092b5204304e296a61229d971af2CAS | 18520976PubMed |
[21] Templeton DJ, Read P, Varma R, Bourne C. Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence. Sex Health 2014; 11 217–29.
| Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence.Crossref | GoogleScholarGoogle Scholar | 24690473PubMed |
[22] Renault CA, Hall C, Kent CK, Klausner JD. Use of NAATs for STD diagnosis of GC and CT in non-FDA-cleared anatomic specimens. MLO Med Lab Obs 2006; 38 10–2.
| 16918168PubMed |
[23] Hook EW, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med 1999; 131 434–7.
| Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK1MXmsFensbY%3D&md5=e98ad79dec4fde437f3e0890fda1803fCAS | 10498560PubMed |
[24] World Health Organization. Report of the expert consultation and review of the latest evidence to update guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2011.
[25] Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 2587–99.
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXit1ansg%3D%3D&md5=6e22600cda8924441c0d2faa55711ff6CAS | 21091279PubMed |
[26] Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, et al Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr 2013; 64 79–86.
| Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXht12jtLrM&md5=8be8e841be989ed187d4c5993ef841b3CAS | 23466649PubMed |
[27] Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al Emtricitabine-tenofovir exposure and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012; 4 1–9.
| Emtricitabine-tenofovir exposure and pre-exposure prophylaxis efficacy in men who have sex with men.Crossref | GoogleScholarGoogle Scholar |
[28] Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis 2014; 14 820–9.
| Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.Crossref | GoogleScholarGoogle Scholar | 25065857PubMed |
[29] Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, et al Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2015; 61 572–80.
| Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind, placebo-controlled trial.Crossref | GoogleScholarGoogle Scholar | 25908682PubMed |
[30] Kojima N, Klausner JD. Is emtricitabine-tenofovir disoproxil fumarate pre-exposure prophylaxis for the prevention of HIV infection safer than aspirin? Open Forum Infect Dis 2016; 3 1–5.
| Is emtricitabine-tenofovir disoproxil fumarate pre-exposure prophylaxis for the prevention of HIV infection safer than aspirin?Crossref | GoogleScholarGoogle Scholar |
[31] Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex. Sex Transm Dis 2015; 42 98–103.
| Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhtlGkt7s%3D&md5=a48908b103d7093d35705109b9545d0fCAS | 25585069PubMed |
[32] Wilson DP, Prestage GP, Gray RT, Hoare A, McCann P, Down I, et al Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men. Sex Transm Dis 2011; 38 573–9.
| Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men.Crossref | GoogleScholarGoogle Scholar | 21343845PubMed |
[33] Boyd MA, Donovan B, Prestage G, Chen M, Petoumenos K, Gray R, et al Is it time to rethink syphilis control? Clin Infect Dis 2015; 60 325–6.
| Is it time to rethink syphilis control?Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC2M3htFyhsw%3D%3D&md5=8652f1dd9c41eb83d06263d607b3dd2bCAS | 25323705PubMed |
[34] Lee TW, Russell L, Deng M, Gibson PR. Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad. Intern Med J 2013; 43 919–26.
| Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXht1CktrbN&md5=9da87cc8d23df1783c476b4b573dc85fCAS | 23656210PubMed |
[35] Angelakis E, Million M, Kankoe S, Lagier JC, Armougom F, Giorgi R, et al Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment. Antimicrob Agents Chemother 2014; 58 3342–7.
| Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment.Crossref | GoogleScholarGoogle Scholar | 24687497PubMed |
[36] Sloan B, Scheinfeld N. The use and safety of doxycycline hyclate and other second-generation tetracyclines. Expert Opin Drug Saf 2008; 7 571–7.
| The use and safety of doxycycline hyclate and other second-generation tetracyclines.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhtVGktrbM&md5=30e4e39e0ca7cdf0bee329ab1bc54bd2CAS | 18759709PubMed |
[37] Scheer S, Chu PL, Klausner JD, Katz MH, Schwarcz SK. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001; 357 432–5.
| Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3M7nt12itA%3D%3D&md5=c1f8936e60354e0c9df5facc7261cbe8CAS | 11273063PubMed |
[38] van der Snoek EM, de Wit JBF, Mulder PGH, van der Meijden WI. Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis 2005; 32 170–5.
| Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 15729154PubMed |
[39] Liu AY, Vittinghoff E, Chillag KL, Mayer KH, Thompson M, Grohskopf L, et al Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr 2013; 64 87–94.
| Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXht12jtLrN&md5=6465fcd1bceec146cfd951255c2a5821CAS | 23481668PubMed |
[40] McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016; 387 53–60.
| Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.Crossref | GoogleScholarGoogle Scholar | 26364263PubMed |
[41] Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med 2016; 176 75–84.
| Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.Crossref | GoogleScholarGoogle Scholar | 26571482PubMed |
[42] Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 2015; 61 1601–3.
| No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting.Crossref | GoogleScholarGoogle Scholar | 26334052PubMed |
[43] British Association for Sexual Health and HIV (BASHH). Recommendations for testing for sexually transmitted infections in men who have sex with men. 2014. Available online at: http://www.bashh.org/documents/BASHH Recommendations for testing for STIs in MSM - FINAL.pdf [verified 10 February 2016].
[44] Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Morb Mortal Wkly Rep 2015; 64 13–6.
[45] Sexually Transmissible Infections in Gay Men Action Group (STIGMA). Australian sexually transmitted infection & HIV testing guidelines 2014 for asymptomatic men who have sex with men. 2014. Available online at: http://stipu.nsw.gov.au/wp-content/uploads/STIGMA_Testing_Guidelines_Final_v5.pdf [verified 10 February 2016].
[46] Liegler T, Abdel-Mohsen M, Bentley LG, Atchison R, Schmidt T, Javier J, et al HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial. J Infect Dis 2014; 210 1217–27.
| HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXhslahsbzO&md5=37d7a246e3f713e7eca1cd84562adf8cCAS | 24740633PubMed |
[47] Weis JF, Baeten JM, McCoy CO, Warth C, Donnell D, Thomas KK, et al Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation. AIDS 2016; 30 31–5.
| Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC28XmvFyqtQ%3D%3D&md5=ae3edf0e94c9bd71cc2490423bfa1270CAS | 26731753PubMed |
[48] Golden MR, Handsfield HH. Preexposure prophylaxis to prevent bacterial sexually transmitted infections in men who have sex with men. Sex Transm Dis 2015; 42 104–6.
| Preexposure prophylaxis to prevent bacterial sexually transmitted infections in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhtlGkt7k%3D&md5=ee5c4f5f81d053c158d424eebce1f056CAS | 25585070PubMed |
[49] Bolding G, Davis M, Hart G, Sherr L, Elford J. Where young MSM meet their first sexual partner: the role of the Internet. AIDS Behav 2007; 11 522–6.
| Where young MSM meet their first sexual partner: the role of the Internet.Crossref | GoogleScholarGoogle Scholar | 17347876PubMed |
[50] Jennings JM, Reilly ML, Perin J, Schumacher C, Sharma M, Safi AG, et al Sex partner meeting places over time among newly HIV-diagnosed men who have sex with men in Baltimore, Maryland. Sex Transm Dis 2015; 42 549–53.
| Sex partner meeting places over time among newly HIV-diagnosed men who have sex with men in Baltimore, Maryland.Crossref | GoogleScholarGoogle Scholar | 26372926PubMed |
[51] McFarlane M, Bull SS, Rietmeijer CA. The Internet as a newly emerging risk environment for sexually transmitted diseases. JAMA 2000; 284 443–6.
| The Internet as a newly emerging risk environment for sexually transmitted diseases.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3czosl2luw%3D%3D&md5=53a6d61e3fd1a336325c674075bc5c19CAS | 10904506PubMed |
[52] Benotsch EG, Kalichman S, Cage M. Men who have met partners via the Internet: prevalence, predictors, and implications for HIV prevention. Arch Sex Behav 2002; 31 177–83.
| Men who have met partners via the Internet: prevalence, predictors, and implications for HIV prevention.Crossref | GoogleScholarGoogle Scholar | 11974643PubMed |
[53] Lewnard JA, Berrang-Ford L. Internet-based partner selection and risk for unprotected anal intercourse in sexual encounters among men who have sex with men: a meta-analysis of observational studies. Sex Transm Infect 2014; 90 290–6.
| Internet-based partner selection and risk for unprotected anal intercourse in sexual encounters among men who have sex with men: a meta-analysis of observational studies.Crossref | GoogleScholarGoogle Scholar | 24518249PubMed |
[54] Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991.
[55] Beymer MR, Weiss RE, Bolan RK, Rudy ET, Bourque LB, Rodriguez JP, et al Sex on-demand: geosocial networking phone apps and risk of sexually transmitted infections among a cross-sectional sample of men who have sex with men in Los Angeles county. Sex Transm Infect 2014; 90 567–72.
| Sex on-demand: geosocial networking phone apps and risk of sexually transmitted infections among a cross-sectional sample of men who have sex with men in Los Angeles county.Crossref | GoogleScholarGoogle Scholar | 24926041PubMed |
[56] Klausner J, Wolf W, Fischer-ponce L, Zolt I, Katz MH. Tracing a syphilis outbreak through cyberspace. JAMA 2000; 284 447–9.
| Tracing a syphilis outbreak through cyberspace.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3czosl2ksg%3D%3D&md5=a53c4a3f20c72adefa09e50c70d99e2eCAS | 10904507PubMed |
[57] Levine D, Woodruff AJ, Mocello AR, Lebrija J, Klausner JD. inSPOT: the first online STD partner notification system using electronic postcards. PLoS Med 2008; 5 e213
| inSPOT: the first online STD partner notification system using electronic postcards.Crossref | GoogleScholarGoogle Scholar | 18942887PubMed |
[58] Bilardi JE, Fairley CK, Hopkins CA, Hocking JS, Kit Sze J, Chen MY. Let them know: evaluation of an online partner notification service for chlamydia that offers e-mail and SMS messaging. Sex Transm Dis 2010; 37 563–5.
| Let them know: evaluation of an online partner notification service for chlamydia that offers e-mail and SMS messaging.Crossref | GoogleScholarGoogle Scholar | 20351621PubMed |
[59] Sun CJ, Stowers J, Miller C, Bachmann LH, Rhodes SD. Acceptability and feasibility of using established geosocial and sexual networking mobile applications to promote HIV and STD testing among men who have sex with men. AIDS Behav 2015; 19 543–52.
| Acceptability and feasibility of using established geosocial and sexual networking mobile applications to promote HIV and STD testing among men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 25381563PubMed |
[60] Holloway IW, Rice E, Gibbs J, Winetrobe H, Dunlap S, Rhoades H. Acceptability of smartphone application-based HIV prevention among young men who have sex with men. AIDS Behav 2014; 18 285–96.
| Acceptability of smartphone application-based HIV prevention among young men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 24292281PubMed |
[61] Levine DK, Scott KC, Klausner JD. Online syphilis testing–confidential and convenient. Sex Transm Dis 2005; 32 139–41.
| Online syphilis testing–confidential and convenient.Crossref | GoogleScholarGoogle Scholar | 15668622PubMed |
[62] Su J-Y, Holt J, Payne R, Gates K, Ewing A, Ryder N. Effectiveness of using Grindr to increase syphilis testing among men who have sex with men in Darwin, Australia. Aust N Z J Public Health 2015; 39 293–4.
| Effectiveness of using Grindr to increase syphilis testing among men who have sex with men in Darwin, Australia.Crossref | GoogleScholarGoogle Scholar | 25716209PubMed |
[63] Brady M, Nardone A, Buenaventura E, Qureshi F, Edwardes D, Kelly P, et al Home HIV sampling linked to national HIV testing campaigns: a novel approach to improve HIV diagnosis. HIV Med 2014; 15 7–8.
[64] Conway DP, Holt M, Couldwell DL, Smith DE, Davies SC, Mcnulty A, et al Barriers to HIV testing and characteristics associated with never testing among gay and bisexual men attending sexual health clinics in Sydney. J Int AIDS Soc 2015; 1–8.
[65] de Wit J, Adam P. To test or not to test: psychosocial barriers to HIV testing in high-income countries. HIV Med 2008; 9 20–2.
| To test or not to test: psychosocial barriers to HIV testing in high-income countries.Crossref | GoogleScholarGoogle Scholar | 18557865PubMed |
[66] Wilkin T. Primary care for men who have sex with men. N Engl J Med 2015; 373 854–62.
| Primary care for men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC28XpslOjsw%3D%3D&md5=b3618c42b677ee1dbc2ac82999d434b7CAS | 26308686PubMed |
[67] Bernstein KT, Liu K-L, Begier EM, Koblin B, Karpati A, Murrill C, et al Same-sex attraction disclosure to health care providers among New York City men who have sex with men. Arch Intern Med 2008; 168 1458–64.
| Same-sex attraction disclosure to health care providers among New York City men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 18625927PubMed |
[68] Wingrove I, McOwan A, Nwokolo N, Whitlock G. Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation. Sex Transm Infect 2014; 90 474
| Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC2M%2FhtFOqsw%3D%3D&md5=02b685f1b8f814c9449180a059c1683cCAS | 25118322PubMed |
[69] Byrne R, Cooper F, Appleby T, Chislett L, Freeman L, Kershaw E, et al Can express treatment reduce onward transmission? Sex Transm Infect 2015; 91 A7
| Can express treatment reduce onward transmission?Crossref | GoogleScholarGoogle Scholar |
[70] Bowles KE, Clark HA, Tai E, Sullivan PS, Song B, Tsang J, et al Implementing rapid HIV testing in outreach and community settings: results from an advancing HIV prevention demonstration project conducted in seven U.S. cities. Public Health Rep 2008; 123 78–85.
| 19172705PubMed |
[71] Meulbroek M, Ditzel E, Saz J, Taboada H, Pérez F, Pérez A, et al BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care. HIV Med 2013; 14 25–8.
| BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care.Crossref | GoogleScholarGoogle Scholar | 24033899PubMed |
[72] Mayer KH, Ducharme R, Zaller ND, Chan PA, Case P, Abbott D, et al Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse. J Acquir Immune Defic Syndr 2012; 59 194–8.
| Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse.Crossref | GoogleScholarGoogle Scholar | 22027871PubMed |
[73] Fajardo-Bernal L, Aponte-Gonzalez J, Vigil P, Angel-Müller E, Rincon C, Gaitán Hernando G, et al Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections. Cochrane Database Syst Rev 2015; 9 3–62.
[74] Sexton ME, Baker JJ, Nakagawa K, Li Y, Perkins R, Slack RS, et al How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men? J Fam Pract 2013; 62 70–8.
| 23405376PubMed |
[75] Chai SJ, Aumakhan B, Barnes M, Jett-Goheen M, Quinn N, Agreda P, et al Internet-based screening for sexually transmitted infections to reach non-clinic populations in the community: risk factors for infection in men. Sex Transm Dis 2010; 37 756–63.
| Internet-based screening for sexually transmitted infections to reach non-clinic populations in the community: risk factors for infection in men.Crossref | GoogleScholarGoogle Scholar | 20644498PubMed |
[76] Young SD, Daniels J, Chiu CJ, Bolan RK, Flynn RP, Kwok J, et al Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study. PLoS One 2014; 9 e103790
| Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study.Crossref | GoogleScholarGoogle Scholar | 25076208PubMed |